Intervention Review

You have free access to this content

Oral treatments for fungal infections of the skin of the foot.

  1. Sally EM Bell-Syer1,*,
  2. Rachel Hart2,
  3. Fay Crawford3,
  4. David J Torgerson4,
  5. Wendy Tyrrell2,
  6. Ian Russell5

Editorial Group: Cochrane Skin Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 4 DEC 2001

DOI: 10.1002/14651858.CD003584

Database Title

Additional Information

How to Cite

Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Tyrrell W, Russell I. Oral treatments for fungal infections of the skin of the foot.. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003584. DOI: 10.1002/14651858.CD003584.

Author Information

  1. 1

    University of York, Department of Health Sciences, York, North Yorkshire, UK

  2. 2

    University of Wales Institute, Faculty of Community Health Sciences, Cardiff, Wales, UK

  3. 3

    The University of Edinburgh, Division of Community Health Sciences, Edinburgh, UK

  4. 4

    University of York, Department of Health Sciences , York, North Yorkshire, UK

  5. 5

    University of Wales Bangor, Institute of Medical and Social Care Research, Bangor, Gwynedd, Wales, UK

*Sally EM Bell-Syer, Department of Health Sciences, University of York, Area 2 Seebohm Rowntree Building, Heslington, York, North Yorkshire, YO10 5DD, UK. sembs1@york.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (299K)Full (379K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 ANTIFUNGAL vs PLACEBO, Outcome 1 Cured (itraconazole, 400 mg/day vs placebo).
[Analysis 1.2]
Analysis 1.2. Comparison 1 ANTIFUNGAL vs PLACEBO, Outcome 2 Cured (terbinafine, 250 mg/day vs placebo).
[Analysis 2.1]
Analysis 2.1. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 1 Cured (terbinafine, 250 mg/day vs itraconazole, 100 mg/day).
[Analysis 2.2]
Analysis 2.2. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 2 Cured (itraconazole, 100 mg/day vs fluconazole, 50 mg/day).
[Analysis 2.3]
Analysis 2.3. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 3 Cured (fluconazole, 50 mg/day vs ketoconazole, 200 mg/day).
[Analysis 2.4]
Analysis 2.4. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 4 Cured (ketaconazole, 200 mg/day vs griseofulvin, 1000 mg/day).
[Analysis 2.5]
Analysis 2.5. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 5 Cured ( terbinafine, 250 mg vs griseofulvin, 500 mg).
[Analysis 2.6]
Analysis 2.6. Comparison 2 DIFFERENT TYPES OF ANTIFUNGALS, Outcome 6 Cured (fluconazole, 150 mg/wk vs fluconazole, 50 mg/day).
[Analysis 3.1]
Analysis 3.1. Comparison 3 PRESENTATION OF TINEA PEDIS, Outcome 1 Plantar tinea pedis.
[Analysis 3.2]
Analysis 3.2. Comparison 3 PRESENTATION OF TINEA PEDIS, Outcome 2 Mixed distribution of tinea pedis.
[Analysis 4.1]
Analysis 4.1. Comparison 4 ADVERSE EVENTS AND LOSS TO FOLLOW-UP, Outcome 1 Summary of adverse events reported for trials of tinea pedis.
View Full Article (HTML) Summary (58K)Standard (299K)Full (379K)